Joshua Rosensweig - Israel Corp External Director

ILCO Stock  ILA 85,770  3,280  3.68%   

Director

Dr. Joshua Rosensweig serves as External Director at Israel Corporation Ltd. since May 8, 2017. He is the chairman of the Compensation, Finance and Balance Sheets committees and member of the Audit committee. His work experience includes the following roles Independent Director at Bezeq The Israeli Telecommunication Corporationration Ltd., Rosetta Genomics Ltd., Plastro Irrigation Systems Ltd. and at various additional companies, Chairman of the Board of Directors at First International Bank of Israel, Senior Partner at Gornitzky and Co., Lecturer at BarIlan University, School of Law School and Lecturer at TelAviv University, School of Business since 2017.
Age 66
Tenure 7 years
Phone972 3 684 4500
Webhttps://www.israelcorp.com
Rosensweig holds a Bachelors degree in Philosophy from Yeshiva University in New York, a LLB degree from the BarIlan University and a Juris Doctor degree in International Taxation and a Master of Legal Letters degree in Taxation, both from the New York University Law School.

Israel Corp Management Efficiency

The company has return on total asset (ROA) of 0.1735 % which means that it generated a profit of $0.1735 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.405 %, meaning that it generated $0.405 on every $100 dollars invested by stockholders. Israel Corp's management efficiency ratios could be used to measure how well Israel Corp manages its routine affairs as well as how well it operates its assets and liabilities.
Israel Corp has accumulated 3.54 B in total debt with debt to equity ratio (D/E) of 1.12, which is about average as compared to similar companies. Israel Corp has a current ratio of 1.61, which is within standard range for the sector. Debt can assist Israel Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Israel Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Israel Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Israel to invest in growth at high rates of return. When we think about Israel Corp's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 12 records

DIRECTOR Age

Yehoshua GleitmanElbit Systems
69
Roberto MignoneTeva Pharmaceutical Industries
47
Ehood NisanElbit Systems
51
Nechemia PeresTeva Pharmaceutical Industries
60
Rosemary CraneTeva Pharmaceutical Industries
59
Gerald LiebermanTeva Pharmaceutical Industries
72
Perry NisenTeva Pharmaceutical Industries
63
JeanMichel HalfonTeva Pharmaceutical Industries
67
Rina BaumElbit Systems
73
Dov NinvehElbit Systems
71
Yuli TamirElbit Systems
65
Yoram BenZeevElbit Systems
74
Israel Corporation Ltd, together with its subsidiaries, engages in the specialty minerals and chemicals, and refining and petrochemicals businesses in Europe, Asia, North America, South America, and internationally. The company was founded in 1968 and is based in Tel Aviv, Israel. THE ISRAEL operates under Specialty Chemicals classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 1341 people. Israel Corp (ILCO) is traded on Tel Aviv Stock Exchange in Israel and employs 1,332 people.

Management Performance

Israel Corp Leadership Team

Elected by the shareholders, the Israel Corp's board of directors comprises two types of representatives: Israel Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Israel. The board's role is to monitor Israel Corp's management team and ensure that shareholders' interests are well served. Israel Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Israel Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Amnon Lion, Director
Joshua Rosensweig, External Director
Maya AlschichKaplan, Gen VP
Aviad Kaufman, Chairman of the Board
Dan Suesskind, Independent Director
Yoav Doppelt, Chief Executive Officer
Tali Michaud, Independent Director
Ovadia Eli, Chairman ORL
Yair Caspi, Director
Idan Hizki, Sr Relations
Jacob Amidror, External & Independent Director
Asher Grinbaum, COO Ltd
Maya Kaplan, Executive Vice President, General Counsel, Company Secretary
Shay Ohayon, Controller
Ofer Alkalay, Internal Auditor
Sagi Kabla, Vice President - Finance

Israel Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Israel Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Israel Stock

Israel Corp financial ratios help investors to determine whether Israel Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Israel with respect to the benefits of owning Israel Corp security.